TWi Pharmaceuticals Inc Stock

TWi Pharmaceuticals, Inc. is engaged in the development, commissioned manufacturing and commissioned research of special pharmaceuticals. The Company focuses on the development of two categories of high barrier generic drugs: Paragraph IV of Abbreviated New Drug Applications (ANDAs) and generics with high technical barriers. The Company is involved in the commissioned manufacture of Divalproex Sodium Extended Release Tablet, which are oral tablets used as antiepileptic drug; the commissioned research and development of generic drugs to meet its customer's specific needs, and the manufacture and sale of oral tablets and capsules used for the treatment of hypertension, depression, and gastro esophageal reflux diseases. The Company distributes its products in the United States and Taiwan.